KindlyMD, Inc. (NASDAQ:NAKA – Free Report) – Equities research analysts at B. Riley issued their FY2027 EPS estimates for shares of KindlyMD in a research note issued on Thursday, November 20th. B. Riley analyst F. Shabalin expects that the company will earn ($0.08) per share for the year. B. Riley currently has a “Buy” rating and a $1.00 target price on the stock.
A number of other equities research analysts have also recently weighed in on the company. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of KindlyMD in a report on Wednesday, October 8th. Wall Street Zen upgraded KindlyMD to a “sell” rating in a report on Saturday, October 18th. Zacks Research raised KindlyMD to a “hold” rating in a report on Friday, October 17th. Finally, Maxim Group assumed coverage on shares of KindlyMD in a research report on Wednesday, September 3rd. They set a “buy” rating and a $8.00 price target on the stock. Two investment analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Hold” and a consensus price target of $4.50.
KindlyMD Stock Down 8.7%
NASDAQ:NAKA opened at $0.44 on Friday. The company has a market capitalization of $194.90 million, a PE ratio of -0.40 and a beta of 30.71. KindlyMD has a 1 year low of $0.44 and a 1 year high of $34.77. The firm has a 50 day moving average price of $0.92.
KindlyMD (NASDAQ:NAKA – Get Free Report) last released its quarterly earnings results on Wednesday, November 19th. The company reported ($0.06) EPS for the quarter, missing analysts’ consensus estimates of ($0.01) by ($0.05). The firm had revenue of $0.39 million during the quarter, compared to analyst estimates of $0.40 million. KindlyMD had a negative net margin of 4,567.90% and a negative return on equity of 13.81%.
KindlyMD Company Profile
Kindly MD, Inc (“KindlyMD” or “Kindly”) is a Utah company formed in 2019. KindlyMD is a healthcare data company, focused on holistic pain management and reducing the impact of the opioid epidemic. KindlyMD offers direct health care to patients integrating prescription medicine and behavioral health services to reduce opioid use in the chronic pain patient population.
Read More
- Five stocks we like better than KindlyMD
- Stock Market Sectors: What Are They and How Many Are There?
- MP Materials Stock Soared After Earnings—Here’s the Real Reason
- Why is the Ex-Dividend Date Significant to Investors?
- Why Palantir Slide May Be a Setup for a Long-Term Opportunity
- What is a Special Dividend?
- Attention Income Investors: This REIT Is on Sale
Receive News & Ratings for KindlyMD Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for KindlyMD and related companies with MarketBeat.com's FREE daily email newsletter.
